Barclays Maintains Underweight on Alignment Healthcare, Raises Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Andrew Mok maintains an Underweight rating on Alignment Healthcare (NASDAQ:ALHC) but raises the price target from $7 to $8.
October 30, 2024 | 2:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays has maintained an Underweight rating on Alignment Healthcare but increased the price target from $7 to $8, indicating a slightly more positive outlook.
The Underweight rating suggests a cautious stance, but the raised price target indicates a slightly improved outlook. This mixed signal may not lead to significant short-term price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100